期刊文献+

中医药联合单药化疗周疗方案治疗老年中晚期肺癌疗效观察

下载PDF
导出
摘要 目的:观察中医药治疗联合单药周疗方案的疗效。方法:将中医药治疗联合单药周疗方案(多西他赛(DOC)35-40mg/m^2(1h)d1,8,15 Q3W或吉西他滨(GEM)1g/m^2(30min)d1,8,15 Q3W的中晚期老年性肺癌病人32例与单纯采用周疗方案的20例病人在疗效、毒副作用、KPS评分及体重变化方面进行评价,共两个周期。结果:中西医治疗组有效率为34.3%,骨髓抑制发生率为0%,胃肠道反应发生率为3.12%,KPS评分提高率为53.12%,体重变化提高率为31.25%;西医组治疗组有效率为25%,骨髓抑制发生率为5%,胃肠道反应发生率为5%,KPS评分提高率为40%,体重变化提高率为15%。结论:中医药与单药周疗化疗方案治疗老年性肺癌有协同作用,可提高疗效,减轻毒副作用。
出处 《内蒙古中医药》 2010年第1期77-78,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献6

  • 1Greenlee RT , Hill --Harmon M , Murray T , et al. Cancer statistics[J]. CA Cancer J Clin ,2001 ,51:151.
  • 2孙燕,石远凯.临床肿瘤内科手册(第5版)[S].人民卫生出版社.2004.160-161.
  • 3杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 4Wasil T , Lichtman SM 1Clinical pharmacology issues relevant to the dosing and toxicit y of chemotherapy drvgs in the elderly[J]. O ncologist , 2005 , 10 (8) : 6021.
  • 5Hainsworth JD ,Burris HA , Erland JB , et al. Phase I / II trial of paelitaxel by 1 --hour infusion ,earboplatin , and gemcitabine in the treatment of patients with advanced non --small cell lung earcinoma[J] . Cancer , 1999 ,85 (6) :1 2691.
  • 6Jatoi A, Hillman S, Stella P, et al. Should elderly non --small--cell lung cancer patients be offered elderly- specific trials Resultsof a pooled analysis from the North Central Cancer TreatmentGroup. J Clin Oncol, 2005, 23: 9113-9119.

二级参考文献23

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Jensen OM, Esteve J, Moller H, et al. Cancer in the European Community and its member states. Eur J Cancer, 1990, 26(11-12): 1167-1256. Erratum in: Eur J Cancer, 1991,27 (12):1717.
  • 4European Network of Cancer Registries (ENCR). (2001) EURO CIM version 4. 0. European Incidence Database V2. 3. Lyon:IARC Press,2001.
  • 5Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer,2002,38(1): 99-166.
  • 6Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005,14(1): 243-250.
  • 7International Agency for Research on Cancer. IARC monographs on the Tobacco Smoke and Involuntary Smoking (Vol. 83). Lyon:IARC Press,2004.
  • 8Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ,1998,317(7170) : 1411-1422.
  • 9Clinical Trial Service Unit, Oxford University. Emerging Tobacco Hazards in China. http:∥rum. ctsu. ox. ac. uk/tobacco.
  • 10Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, Version 2. 0. IARC CancerBase No. 5. Lyon: IARC Press,2004.

共引文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部